Leon O. Murphy PhD
Casma Therapeutics
Leon Murphy leads a drug discovery group at Novartis that works on autophagy, the microbiome and metabolic disorders. His team has used large-scale genomics and proteomics to probe the role of autophagy in cancer and to better define the process of selective autophagy.
Appearances
CHEWING THE FAT: PANEL AND DISCUSSION ABOUT AUTOPHAGY AND FUTURE DIRECTIONS OF THE AUTOPHAGY FIELDModerator
Eric H. Baehrecke, PhDUniversity of Massachusetts Medical SchoolPanelists
Ana Maria Cuevo, MD, PhDAlbert Einstein College of MedicineVojo Deretic, PhDUniversity of New Mexico Health Sciences CenterLeon O. Murphy, PhDCasma TherapeuticsFreeStandard Price
AUTOPHAGY: CONTROVERSIES, CHALLENGES & OPPORTUNITIESModerator
Eric H. Baehrecke, PhDUniversity of Massachusetts Medical SchoolPanelists
Ana Maria Cuevo, MD, PhDAlbert Einstein College of MedicineVojo Deretic, PhDUniversity of New Mexico Health Sciences CenterLeon O. Murphy, PhDCasma TherapeuticsFreeStandard Price
DateFebruary 12, 2020Autophagy is a homeostatic process strategically positioned at the intersection of metabolism and intracellular quality control, with broad physiological and medical manifestations ranging from metabolic imbalance to neurodegeneration, infections, immune disorders, cancer and aging…Moderator
Vojo Deretic, PhDUniversity of New Mexico Health Sciences CenterPanelists
Leon O. Murphy, PhDCasma TherapeuticsRushika M. Perera, PhDUniversity of California, San FranciscoKevin M. Ryan, PhDBeatson Institute for Cancer ResearchFreeStandard Price
DateOctober 7, 2020Jennifer Martinez, NIEHS, National Institutes of HealthPanelists
Jennifer Martinez, PhDNIEHS, National Institutes of HealthAlicia Melendez, PhDQueens College ‑ CUNYLeon O. Murphy, PhDCasma Therapeutics
